Yanzhong Xin

481 total citations
17 papers, 271 citations indexed

About

Yanzhong Xin is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanzhong Xin has authored 17 papers receiving a total of 271 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 7 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanzhong Xin's work include Esophageal Cancer Research and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Gastric Cancer Management and Outcomes (4 papers). Yanzhong Xin is often cited by papers focused on Esophageal Cancer Research and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Gastric Cancer Management and Outcomes (4 papers). Yanzhong Xin collaborates with scholars based in China and United States. Yanzhong Xin's co-authors include Shouqiang Cao, Guibin Zhao, Hongfei Cai, Youbin Cui, Qing Dong, Hao Liang, Jian Cui, Baozhong Shen, Jianqun Ma and Qingfeng Guo and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and BioMed Research International.

In The Last Decade

Yanzhong Xin

17 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanzhong Xin China 9 111 100 97 51 44 17 271
Wenjuan Yu China 12 178 1.6× 51 0.5× 77 0.8× 147 2.9× 88 2.0× 40 314
Xuezhu Wang China 9 75 0.7× 99 1.0× 63 0.6× 32 0.6× 132 3.0× 37 331
Songqi Li China 9 76 0.7× 154 1.5× 45 0.5× 96 1.9× 38 0.9× 23 319
Peter Saliba‐Gustafsson Sweden 7 55 0.5× 44 0.4× 40 0.4× 23 0.5× 64 1.5× 14 202
Sadaf S. Mughal Germany 10 106 1.0× 64 0.6× 29 0.3× 80 1.6× 84 1.9× 15 278
Beibei Mao China 8 63 0.6× 43 0.4× 43 0.4× 55 1.1× 86 2.0× 25 202
Songfeng Zhao China 8 100 0.9× 22 0.2× 70 0.7× 53 1.0× 49 1.1× 18 255
Jawhar Rawwas United States 8 130 1.2× 26 0.3× 67 0.7× 44 0.9× 39 0.9× 11 245
Neha Varshney United States 6 85 0.8× 52 0.5× 84 0.9× 115 2.3× 33 0.8× 29 239
Eiichiro Toyama Japan 6 222 2.0× 85 0.8× 202 2.1× 63 1.2× 34 0.8× 21 339

Countries citing papers authored by Yanzhong Xin

Since Specialization
Citations

This map shows the geographic impact of Yanzhong Xin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanzhong Xin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanzhong Xin more than expected).

Fields of papers citing papers by Yanzhong Xin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanzhong Xin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanzhong Xin. The network helps show where Yanzhong Xin may publish in the future.

Co-authorship network of co-authors of Yanzhong Xin

This figure shows the co-authorship network connecting the top 25 collaborators of Yanzhong Xin. A scholar is included among the top collaborators of Yanzhong Xin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanzhong Xin. Yanzhong Xin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Liang, Hao, et al.. (2024). Surgical technique of da Vinci robotic-assisted minimally invasive esophagectomy(RAMIE) expert experiences. SHILAP Revista de lepidopterología. 7. 12–20. 1 indexed citations
2.
3.
Yang, Yingnan, Hongxue Meng, Xiaodong Ling, et al.. (2023). Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study). International Journal of Surgery. 110(3). 1430–1440. 14 indexed citations
4.
Wang, Xiaoyuan, Xiaodong Ling, Changhong Wang, et al.. (2022). Response to neoadjuvant immune checkpoint inhibitors and chemotherapy in Chinese patients with esophageal squamous cell carcinoma: the role of tumor immune microenvironment. Cancer Immunology Immunotherapy. 72(6). 1619–1631. 10 indexed citations
5.
Ma, Jianqun, Jinfeng Zhang, Yingnan Yang, et al.. (2021). 405 Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): a phase II, single-arm, exploratory research. Regular and Young Investigator Award Abstracts. A436–A436. 1 indexed citations
6.
Ma, Jianqun, Jinfeng Zhang, Yingnan Yang, et al.. (2021). Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase Ⅱ, single-arm, exploratory research.. Journal of Clinical Oncology. 39(15_suppl). e16033–e16033. 7 indexed citations
7.
Ma, Jianqun, Jinfeng Zhang, Yingnan Yang, et al.. (2021). 406 Camrelizumab combined with paclitaxel and nedaplatin in the first-line treatment of locally advanced/advanced esophageal squamous cell carcinoma: a phase II, single-arm, exploratory research. Regular and Young Investigator Award Abstracts. A437–A437. 1 indexed citations
8.
9.
Wang, Xiaoyuan, Hang Yin, Dayong Zheng, et al.. (2019). The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small cell lung cancer. Journal of Thoracic Disease. 11(5). 1772–1778. 45 indexed citations
10.
Xin, Yanzhong, Hongfei Cai, Yang Li, & Youbin Cui. (2017). Thymic hyperplasia associated with primary Sjogren’s syndrome cured by thymectomy. Journal of Thoracic Disease. 9(2). E130–E132. 8 indexed citations
11.
Xin, Yanzhong, et al.. (2016). The Effect of Immunonutrition on the Postoperative Complications in Thymoma with Myasthenia Gravis. Mediators of Inflammation. 2016. 1–8. 9 indexed citations
12.
Xin, Yanzhong, Hongfei Cai, Tianyu Lu, et al.. (2016). miR-20b Inhibits T Cell Proliferation and Activation via NFAT Signaling Pathway in Thymoma-Associated Myasthenia Gravis. BioMed Research International. 2016. 1–12. 38 indexed citations
13.
Zhao, Guibin, Lijie Liu, Sibo Jiang, et al.. (2015). Upregulation of miR-24 promotes cell proliferation by targeting NAIF1 in non-small cell lung cancer. Tumor Biology. 36(5). 3693–3701. 47 indexed citations
14.
Zhao, Guibin, Shouqiang Cao, Kai Zhang, et al.. (2014). [Effect of early enteral nutrition on immune response and clinical outcomes after esophageal cancer surgery].. PubMed. 17(4). 356–60. 7 indexed citations
15.
Cao, Shouqiang, Guibin Zhao, Qing Dong, et al.. (2013). [Mechanisms of EGF regulation of COX-2 through the STAT5 signaling pathway in human lung adenocarcinoma A549 cells].. SHILAP Revista de lepidopterología. 16(4). 169–76. 1 indexed citations
16.
Cao, Shouqiang, Guibin Zhao, Jian Cui, et al.. (2012). Fast-track rehabilitation program and conventional care after esophagectomy: a retrospective controlled cohort study. Supportive Care in Cancer. 21(3). 707–714. 57 indexed citations
17.
Cao, Shouqiang, Kai Zhang, Guibin Zhao, et al.. (2012). Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions. Journal of Cardiothoracic Surgery. 7(1). 121–121. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenjuan Yu Breakdown of academic impact, for papers by Xuezhu Wang Breakdown of academic impact, for papers by Songqi Li Breakdown of academic impact, for papers by Peter Saliba‐Gustafsson Breakdown of academic impact, for papers by Sadaf S. Mughal Breakdown of academic impact, for papers by Beibei Mao Breakdown of academic impact, for papers by Songfeng Zhao Breakdown of academic impact, for papers by Jawhar Rawwas Breakdown of academic impact, for papers by Neha Varshney Breakdown of academic impact, for papers by Eiichiro Toyama
Rankless by CCL
2026